Catalyst Pharmaceuticals (NASDAQ:CPRX) reported quarterly earnings of $0.68 per share which beat the analyst consensus estimate of $0.53 by 28.3 percent. This is a 78.95 percent increase over earnings of $0.38 per share from the same period last year. The company reported quarterly sales of $141.42 million which beat the analyst consensus estimate of $130.86 million by 8.07 percent. This is a 43.56 percent increase over sales of $98.51 million the same period last year.